ISC-话题@MedSci

#ISC#

225篇内容 | 3778人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587818, encodeId=ba16158e818ff, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Slas Discovery：骨关节炎疼痛的新治疗靶点, objectType=article, longId=111156, objectId=f4d411115669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4d411115669, replyNumber=0, likeNumber=73, createdTime=2017-08-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4d411115669, moduleTitle=Slas Discovery：骨关节炎疼痛的新治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4d411115669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587817, encodeId=e436158e8177e, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Discovery：上海药物所高召兵组发现治疗杀虫剂和化学武器致神经损伤的药物, objectType=article, longId=107464, objectId=7aa110e464de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa110e464de, replyNumber=0, likeNumber=72, createdTime=2017-08-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa110e464de, moduleTitle=Cell Discovery：上海药物所高召兵组发现治疗杀虫剂和化学武器致神经损伤的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa110e464de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587816, encodeId=1289158e8160c, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=CANCER DISCOV：面对不断进化的肿瘤，我们该如何设计新药？, objectType=article, longId=106593, objectId=ec3210659347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec3210659347, replyNumber=0, likeNumber=64, createdTime=2017-07-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec3210659347, moduleTitle=CANCER DISCOV：面对不断进化的肿瘤，我们该如何设计新药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec3210659347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587815, encodeId=21f2158e81531, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！, objectType=article, longId=106152, objectId=717f10615212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=717f10615212, replyNumber=0, likeNumber=75, createdTime=2017-07-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=717f10615212, moduleTitle=Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=717f10615212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587814, encodeId=1452158e81453, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=NAT REV DRUG DISCOV:点赞！自信走向世界的中国生物医药, objectType=article, longId=104090, objectId=55e31040908b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55e31040908b, replyNumber=0, likeNumber=59, createdTime=2017-07-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e31040908b, moduleTitle=NAT REV DRUG DISCOV:点赞！自信走向世界的中国生物医药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e31040908b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587813, encodeId=1f7e158e81326, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discov：三位一体全新血液检测技术，可为前列腺癌患者提供精准治疗, objectType=article, longId=102592, objectId=4e4210259295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e4210259295, replyNumber=0, likeNumber=72, createdTime=2017-06-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e4210259295, moduleTitle=Cancer Discov：三位一体全新血液检测技术，可为前列腺癌患者提供精准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e4210259295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587812, encodeId=bc47158e81273, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计, objectType=article, longId=100264, objectId=f46810026402, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f46810026402, replyNumber=0, likeNumber=69, createdTime=2017-06-02, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f46810026402, moduleTitle=NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f46810026402)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587811, encodeId=378f158e81135, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战, objectType=article, longId=97299, objectId=9cb69e299a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cb69e299a7, replyNumber=0, likeNumber=67, createdTime=2017-04-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cb69e299a7, moduleTitle=NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cb69e299a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587810, encodeId=88a0158e81073, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞, objectType=article, longId=97116, objectId=3f879e116e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f879e116e5, replyNumber=0, likeNumber=85, createdTime=2017-04-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f879e116e5, moduleTitle=Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f879e116e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587809, encodeId=b4d1158e80934, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Discov：生态中心汪海林研究组在DNA损伤修复研究方面取得进展, objectType=article, longId=96772, objectId=668b96e72d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=668b96e72d9, replyNumber=0, likeNumber=88, createdTime=2017-04-23, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=668b96e72d9, moduleTitle=Cell Discov：生态中心汪海林研究组在DNA损伤修复研究方面取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=668b96e72d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587808, encodeId=11e1158e8089f, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cell Discovery：上海巴斯德所揭示迷走神经调控急性肺部感染免疫的新机理, objectType=article, longId=96508, objectId=19ca965087e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ca965087e, replyNumber=0, likeNumber=70, createdTime=2017-04-21, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ca965087e, moduleTitle=Cell Discovery：上海巴斯德所揭示迷走神经调控急性肺部感染免疫的新机理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ca965087e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587807, encodeId=82f0158e8073c, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=2017 ISC：脑出血到底有没有止血药？, objectType=article, longId=92225, objectId=172292225c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172292225c5, replyNumber=0, likeNumber=98, createdTime=2017-03-19, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172292225c5, moduleTitle=2017 ISC：脑出血到底有没有止血药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172292225c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587806, encodeId=48a9158e806ef, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discovery：科学家发现侵袭性乳腺癌抵抗药物新机制, objectType=article, longId=88015, objectId=f7188801597, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7188801597, replyNumber=0, likeNumber=63, createdTime=2017-01-25, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7188801597, moduleTitle=Cancer Discovery：科学家发现侵袭性乳腺癌抵抗药物新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7188801597)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587805, encodeId=3e85158e80501, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discovery：癌细胞可清理自身突变躲避免疫治疗, objectType=article, longId=86978, objectId=d747869e8e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d747869e8e2, replyNumber=0, likeNumber=67, createdTime=2017-01-09, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d747869e8e2, moduleTitle=Cancer Discovery：癌细胞可清理自身突变躲避免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d747869e8e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587804, encodeId=31fe158e80489, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验, objectType=article, longId=82507, objectId=ed668250e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed668250e5a, replyNumber=0, likeNumber=25, createdTime=2016-11-18, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed668250e5a, moduleTitle=NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed668250e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587803, encodeId=4c08158e80396, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discov：雌激素驱动免疫抑制，促进肿瘤恶化, objectType=article, longId=81396, objectId=2bec8139662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bec8139662, replyNumber=0, likeNumber=60, createdTime=2016-10-31, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bec8139662, moduleTitle=Cancer Discov：雌激素驱动免疫抑制，促进肿瘤恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bec8139662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587802, encodeId=8127158e80249, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=IT**学者Jaenisch实验室《Cell》发布基因组DNA甲基化编辑技术, objectType=article, longId=78287, objectId=d1d6e828752, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d6e828752, replyNumber=0, likeNumber=55, createdTime=2016-09-25, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d6e828752, moduleTitle=IT**学者Jaenisch实验室《Cell》发布基因组DNA甲基化编辑技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d6e828752)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587801, encodeId=7ba9158e80179, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discov：英国女科学家Nature之后再发白血病治疗重磅研究, objectType=article, longId=77704, objectId=8df8e77043f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df8e77043f, replyNumber=0, likeNumber=72, createdTime=2016-09-19, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df8e77043f, moduleTitle=Cancer Discov：英国女科学家Nature之后再发白血病治疗重磅研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df8e77043f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587800, encodeId=fdf6158e8002b, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Lancet：非ST段抬高急性冠状动脉综合征患者应优先选择早期介入治疗（FRISC-II研究）, objectType=article, longId=76220, objectId=2d6ce62207f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6ce62207f, replyNumber=0, likeNumber=69, createdTime=2016-09-01, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6ce62207f, moduleTitle=Lancet：非ST段抬高急性冠状动脉综合征患者应优先选择早期介入治疗（FRISC-II研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d6ce62207f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587799, encodeId=83ce158e799d7, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, objectTitle=Cancer Discov：揭示肥胖阻断胰腺癌化疗疗效机制, objectType=article, longId=72473, objectId=6f1fe2473e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1fe2473e7, replyNumber=0, likeNumber=92, createdTime=2016-07-12, rootId=0, userName=yankaienglish, userId=173417575755, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1fe2473e7, moduleTitle=Cancer Discov：揭示肥胖阻断胰腺癌化疗疗效机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1fe2473e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ISC

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

Slas Discovery：骨关节炎疼痛的新治疗靶点

2017-08-30

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

Cell Discovery：上海药物所高召兵组发现治疗杀虫剂和化学武器致神经损伤的药物

2017-08-03

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

CANCER DISCOV：面对不断进化的肿瘤，我们该如何设计新药？

2017-07-26

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

Discov Med.：netrin-1在血管生成和糖尿病性视网膜病变中的作用：潜在治疗策略！

2017-07-22

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

NAT REV DRUG DISCOV:点赞！自信走向世界的中国生物医药

2017-07-01

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

Cancer Discov：三位一体全新血液检测技术，可为前列腺癌患者提供精准治疗

2017-06-22

仁心济世 (审核中...)

前往app查看评论内容

#ISC#

NAT REV DRUG DISCOV：对著名制药企业研发投入的十年统计

2017-06-02

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

NAT REV DRUG DISCOV：开发下一代抗体-药物偶联物（ADC）的策略和挑战

2017-04-28

仁者大医 (审核中...)

前往app查看评论内容

#ISC#

Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞

2017-04-27

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Discov：生态中心汪海林研究组在DNA损伤修复研究方面取得进展

2017-04-23

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cell Discovery：上海巴斯德所揭示迷走神经调控急性肺部感染免疫的新机理

2017-04-21

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

2017 ISC：脑出血到底有没有止血药？

2017-03-19

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discovery：科学家发现侵袭性乳腺癌抵抗药物新机制

2017-01-25

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discovery：癌细胞可清理自身突变躲避免疫治疗

2017-01-09

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

NAT REV DRUG DISCOV：耳聋治疗药物进入临床试验

2016-11-18

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discov：雌激素驱动免疫抑制，促进肿瘤恶化

2016-10-31

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

IT**学者Jaenisch实验室《Cell》发布基因组DNA甲基化编辑技术

2016-09-25

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discov：英国女科学家Nature之后再发白血病治疗重磅研究

2016-09-19

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Lancet：非ST段抬高急性冠状动脉综合征患者应优先选择早期介入治疗（FRISC-II研究）

2016-09-01

yankaienglish (审核中...)

前往app查看评论内容

#ISC#

Cancer Discov：揭示肥胖阻断胰腺癌化疗疗效机制

2016-07-12

科室
- - 订阅+
  - 更多科室
工具
服务